Structured evidence table for Saccharomyces Boulardii Gut Health Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Saccharomyces Boulardii Gut Health Meta-Analysis | These benefits include modulation of the gut microbiota, enhancement of immune function, and alleviation of symptoms associated with gastrointestinal disorders. | 3 | Dong Z (2026) | <i>Saccharomyces boulardii</i> as a probiotic yeast in food applications and its health properties: a review and future perspectives. |
| Saccharomyces Boulardii Gut Health Meta-Analysis | The review also covers advances in genetic engineering approaches aimed at enhancing its probiotic functions, as well as the technical, regulatory, and safety limitations associated with its application in food products. | 3 | Dong Z (2026) | <i>Saccharomyces boulardii</i> as a probiotic yeast in food applications and its health properties: a review and future perspectives. |
| Saccharomyces Boulardii Gut Health Meta-Analysis | Finally, in light of current bottlenecks associated with its industrial application, future research directions are proposed. | 3 | Dong Z (2026) | <i>Saccharomyces boulardii</i> as a probiotic yeast in food applications and its health properties: a review and future perspectives. |
| Saccharomyces Boulardii Gut Health Meta-Analysis | Saccharomyces boulardii is currently the only probiotic yeast with established clinical validation for use in both humans and livestock. | 3 | Dong Z (2026) | <i>Saccharomyces boulardii</i> as a probiotic yeast in food applications and its health properties: a review and future perspectives. |
| Saccharomyces Boulardii Gut Health Meta-Analysis | Additionally, the findings demonstrated that the administration ofsignificantly reduced the escape latency of the Sb + LPS group in comparison to the LPS group on days 3–4 (a;and, respectively). | 4 | Akhbari Masoume (2026) | The effects of Saccharomyces boulardii on TLR4/NF-κB neuroinflammatory pathway in the hippocampus of LPS-induced rats |
| Saccharomyces Boulardii Gut Health Meta-Analysis | boulardii In the probe test, the LPS group exhibited a significantly reduced time in the target quadrant compared to the control group (d). | 4 | Akhbari Masoume (2026) | The effects of Saccharomyces boulardii on TLR4/NF-κB neuroinflammatory pathway in the hippocampus of LPS-induced rats |
| Saccharomyces Boulardii Gut Health Meta-Analysis | Pretreatment withsignificantly reduced LPS-induced elevated hippocampal NF-κB and IL−1β expression levels in Sb + LPS groups (c;andd;respectively), but not for TLR4 and TNF-α (b and e), in Sb + LPS groups compared to LPS groups. | 4 | Akhbari Masoume (2026) | The effects of Saccharomyces boulardii on TLR4/NF-κB neuroinflammatory pathway in the hippocampus of LPS-induced rats |
| Saccharomyces Boulardii Gut Health Meta-Analysis | Inan et al., 2025 Yang et al., 2024 Olejnik, et al., 2025 Jiang et al., 2017 Suganya and Koo, 2020 Magistrelli et al., 2019 Tankou et al., 2018 Magistrelli et al., 2019 Mohammadi et al., 2019a Tankou et al., 2018 Babaei et al., 2022b Sarkar et al., 2021 Tao et al., 2021 Liang et al., 2020 Padurariu et al., 2012 Samal et al., 2019 Saccharomyces boulardii S. | 4 | Akhbari Masoume (2026) | The effects of Saccharomyces boulardii on TLR4/NF-κB neuroinflammatory pathway in the hippocampus of LPS-induced rats |
Source documents